US5656286A
(en)
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5474783A
(en)
*
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5103812A
(en)
*
|
1988-10-12 |
1992-04-14 |
Rochal Industries, Inc. |
Conformable bandage and coating material
|
US5246705A
(en)
*
|
1992-04-08 |
1993-09-21 |
Cygnus Therapeutic System |
Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
|
US5288827A
(en)
*
|
1993-02-17 |
1994-02-22 |
Ciba-Geigy Corporation |
Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives
|
GB9411530D0
(en)
*
|
1994-06-09 |
1994-08-03 |
Quayle Rachel A |
Use of polymers as film-forming barrier materials
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
JP4330175B2
(ja)
*
|
1995-06-07 |
2009-09-16 |
デュレクト コーポレイション |
高粘度液体による制御された送達系
|
US6730380B2
(en)
|
1996-02-20 |
2004-05-04 |
Safeskin Corp. |
Readily-donned elastomeric articles
|
US5948400A
(en)
*
|
1997-11-20 |
1999-09-07 |
Smith & Nephew Inc. |
Method of applying a pressure-sensitive adhesive wound dressing and water-based skin treatment composition
|
WO1999026571A1
(en)
*
|
1997-11-25 |
1999-06-03 |
Theratech, Inc. |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
|
DE60030542T2
(de)
|
1999-03-25 |
2007-06-06 |
3M Innovative Properties Co., Saint Paul |
Nicht stechendes überzugsmittel
|
US6471985B2
(en)
*
|
1999-06-04 |
2002-10-29 |
Bahman Guyuron |
Use of RTV silicone compositions for wound dressing
|
GB0003632D0
(en)
*
|
2000-02-16 |
2000-04-05 |
Univ Hong Kong Science & Techn |
Dimeric compounds
|
US6512072B1
(en)
|
2000-06-12 |
2003-01-28 |
Dow Corning Corporation |
Fast cure film forming formulation
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US6942875B2
(en)
*
|
2001-07-05 |
2005-09-13 |
Closure Medical Corporation |
Adhesive treatment for skin yeast infections
|
US6602496B2
(en)
|
2001-07-05 |
2003-08-05 |
Closure Medical Corporation |
Adhesive treatment for tinea corporis
|
US6585967B2
(en)
|
2001-07-05 |
2003-07-01 |
Closure Medical Corporation |
Adhesive treatment for tinea cruris
|
US6746667B2
(en)
|
2001-07-05 |
2004-06-08 |
Closure Medical Corporation |
Adhesive treatment for tinea pedis
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
DK1575569T3
(da)
|
2002-12-13 |
2011-01-10 |
Durect Corp |
Oralt indgivelsessystem omfattende flydende bærematerialer med høj viskositet
|
US20040122382A1
(en)
*
|
2002-12-23 |
2004-06-24 |
Kimberly-Clark Worldwide, Inc. |
Elastomeric articles with beneficial coating on a surface
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
US20050031817A1
(en)
*
|
2003-08-07 |
2005-02-10 |
Littleton Kermit R. |
Readily donned, powder-free elastomeric article
|
US20050129937A1
(en)
*
|
2003-12-16 |
2005-06-16 |
Eastman Kodak Company |
Antimicrobial web for application to a surface
|
US7842749B2
(en)
*
|
2004-08-02 |
2010-11-30 |
Poly-Med, Inc. |
Tissue protecting spray-on copolymeric film composition
|
US20060030808A1
(en)
*
|
2004-08-09 |
2006-02-09 |
Aso Corporation |
Liquid bandage and tissue sealant
|
EA014852B1
(ru)
|
2004-09-17 |
2011-02-28 |
Дьюрект Корпорейшн |
Система контролируемой доставки
|
EP1833918B1
(de)
|
2004-12-23 |
2011-09-28 |
Dow Corning Corporation |
Vernetzbare saccharid-siloxan-zusammensetzungen und daraus gebildete netzwerke, überzüge und artikel
|
JP4704764B2
(ja)
*
|
2005-02-03 |
2011-06-22 |
日東電工株式会社 |
爪貼付用粘着組成物および爪用貼付剤
|
US7318937B2
(en)
*
|
2005-03-18 |
2008-01-15 |
Closure Medical Corporation |
Liquid coating compositions
|
WO2006127883A2
(en)
|
2005-05-23 |
2006-11-30 |
Dow Corning Corporation |
Personal care compositions comprising saccharide-siloxane copolymers
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
JP5567270B2
(ja)
*
|
2005-08-17 |
2014-08-06 |
ロチャル インダストリーズ エルエルピー |
液体コーティング材料及びキット
|
US7795326B2
(en)
*
|
2005-12-07 |
2010-09-14 |
Rochal Industries, Llp |
Conformable bandage and coating material
|
CN101478973B
(zh)
|
2006-05-23 |
2013-08-28 |
陶氏康宁公司 |
用于递送活性成分的新型硅氧烷成膜剂
|
CN103480026A
(zh)
*
|
2007-03-08 |
2014-01-01 |
莫科治疗有限公司 |
一种疤痕敷料制剂
|
US8173146B2
(en)
*
|
2007-04-23 |
2012-05-08 |
Safen'Simple LLC |
Stoma wipe and adhesive remover and method
|
US20080302827A1
(en)
*
|
2007-06-06 |
2008-12-11 |
Gerrish Donald L |
Spray dispenser
|
AU2008347158B8
(en)
|
2007-12-06 |
2013-08-22 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US8852558B2
(en)
*
|
2008-03-11 |
2014-10-07 |
Materials Modification, Inc. |
In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
|
US8828358B2
(en)
*
|
2008-03-11 |
2014-09-09 |
Materials Modifications, Inc. |
In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
|
MX2010014358A
(es)
|
2008-06-20 |
2011-07-04 |
Wyeth Llc |
Composiciones y metodos de uso del orf1358 de cepas estreptococicas beta-hemoliticas.
|
US8003132B2
(en)
|
2008-06-30 |
2011-08-23 |
Johnson & Johnson Consumer Companies, Inc. |
Compositions comprising an ultraviolet radiation-absorbing polymer
|
US8563697B2
(en)
|
2008-08-14 |
2013-10-22 |
Cephalon Australia Pty. Ltd. |
Anti-IL-12/IL-23 antibodies
|
DE102008048338A1
(de)
|
2008-09-22 |
2010-03-25 |
Beiersdorf Ag |
Wundversorgungszubereitung mit verminderten Hautirritationen
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
DE102008060904A1
(de)
*
|
2008-12-09 |
2010-06-10 |
Beiersdorf Ag |
Wasserlösliche Wirkstoffe in Sprühpflaster
|
US8957277B2
(en)
|
2009-04-27 |
2015-02-17 |
Avery Dennison Corporation |
Disruptable adhesive layer for fluid activated debonding
|
CN102782069B
(zh)
|
2009-04-27 |
2014-03-19 |
艾利丹尼森公司 |
用于根据需要运送和脱粘的系统、方法和材料
|
US8828425B2
(en)
*
|
2010-02-02 |
2014-09-09 |
Poly-Med, Inc. |
In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
|
US8475774B2
(en)
|
2010-02-08 |
2013-07-02 |
Johnson & Johnson Consumer Companies, Inc. |
Sunscreen compositions comprising an ultraviolet radiation-absorbing polymer
|
JP5997155B2
(ja)
|
2010-08-23 |
2016-09-28 |
ダウ コーニング コーポレーションDow Corning Corporation |
水性環境で安定している糖シロキサン並びにそのような糖シロキサンの調製及び使用方法
|
JP5754665B2
(ja)
*
|
2010-10-22 |
2015-07-29 |
アルケア株式会社 |
皮膚の痛み緩和用皮膜形成組成物
|
EP2741788A4
(de)
|
2011-08-14 |
2015-03-25 |
Materials Modification Inc |
Verfahren und zusammensetzung zur in-situ-bildung einer künstlichen sperre zur bekämpfung von blutverlust
|
BR112014007522A2
(pt)
|
2011-09-30 |
2017-04-25 |
3M Innovative Properties Co |
"composição de revestimento conformável e filme conformável"
|
US8263720B1
(en)
*
|
2011-10-05 |
2012-09-11 |
Rochal Industries, Llp |
Sacrificial adhesive coatings
|
DK2773304T3
(en)
|
2011-10-31 |
2016-05-02 |
Avery Dennison Corp |
Adhesive layers, which can be torn apart, to the fluid-activated solution.
|
CN104870567B
(zh)
|
2012-10-22 |
2018-09-07 |
艾利丹尼森公司 |
分散在胶黏剂中的交联的微凝胶颗粒的杂化材料
|
US20150231300A1
(en)
*
|
2012-10-28 |
2015-08-20 |
Peritech Pharma Ltd. |
Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
|
AU2013341646B2
(en)
|
2012-11-06 |
2017-08-31 |
Rochal Technologies, Llc |
Delivery of biologically-active agents using volatile, hydrophobic solvents
|
JP2016510807A
(ja)
|
2013-03-10 |
2016-04-11 |
ペリテック・ファーマ・リミテッドPeritech Pharma Ltd. |
局所組成物および局所障害の処置方法
|
US20140272129A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Apple Inc. |
Compliant permeable glue applicator
|
CN105120659A
(zh)
|
2013-03-15 |
2015-12-02 |
度瑞公司 |
用于降低溶解可变性的具有流变改性剂的组合物
|
US9901366B2
(en)
*
|
2013-07-27 |
2018-02-27 |
Lawrence A. Colby |
Systems and methods for enhancing the visibility of medical items
|
US8877882B1
(en)
|
2013-10-04 |
2014-11-04 |
Rochal Industries Llp |
Non-self-adherent coating materials
|
PL3712174T3
(pl)
|
2013-12-24 |
2022-07-04 |
Janssen Pharmaceutica Nv |
Przeciwciała i fragmenty anty-vista
|
EP3116962B1
(de)
|
2014-03-10 |
2019-10-30 |
3M Innovative Properties Company |
Zusammensetzung für anpassungsfähige beschichtung
|
US10287398B2
(en)
*
|
2014-12-30 |
2019-05-14 |
Momentive Performance Materials Inc. |
Siloxane coordination polymers
|
US9815045B2
(en)
|
2015-03-23 |
2017-11-14 |
Clariant Corporation |
Metal oxide catalyst material and processes for making and using same
|
WO2016164316A1
(en)
|
2015-04-06 |
2016-10-13 |
3M Innovative Properties Company |
Removable film forming gel compositions and methods for their application
|
JP7026509B2
(ja)
|
2015-06-24 |
2022-02-28 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体およびフラグメント
|
CN116920085A
(zh)
|
2016-02-12 |
2023-10-24 |
詹森药业有限公司 |
抗-vista(b7h5)抗体
|
AU2017241776A1
(en)
|
2016-03-29 |
2018-10-11 |
Janssen Biotech, Inc. |
Treating psoriasis with increased interval dosing of anti-IL12 and/or -23 antibody
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
MX2019003703A
(es)
|
2016-09-30 |
2020-08-13 |
Janssen Biotech Inc |
Método seguro y eficaz para tratar la psoriasis con el anticuerpo específico anti-il23.
|
US20190381208A1
(en)
*
|
2016-10-13 |
2019-12-19 |
3M Innovative Properties Company |
Removable Film Forming Gel Compositions Featuring Adhesion Promoters
|
AU2017362222A1
(en)
|
2016-11-16 |
2019-05-30 |
Janssen Biotech, Inc. |
Method of treating psoriasis with anti-IL-23 specific antibody
|
CA3052095A1
(en)
|
2017-01-30 |
2018-08-02 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
|
MA47442A
(fr)
|
2017-02-07 |
2019-12-18 |
Janssen Biotech Inc |
Anticorps anti-tnf, compositions et méthodes pour le traitement de la spondylarthrite ankylosante active
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
JP2021515770A
(ja)
|
2018-03-05 |
2021-06-24 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il−23特異的抗体を用いたクローン病の治療方法
|
WO2020016838A2
(en)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Sustained response predictors after treatment with anti-il23 specific antibody
|
DK3883606T5
(da)
|
2018-09-24 |
2024-01-02 |
Janssen Biotech Inc |
Sikker og effektiv fremgangsmåde til behandling af colitis ulcerosa med anti-il12/il23-antistof
|
WO2020104943A2
(en)
|
2018-11-20 |
2020-05-28 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il-23 specific antibody
|
US20200197517A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
|
BR112021013903A2
(pt)
|
2019-01-15 |
2021-09-21 |
Janssen Biotech, Inc. |
Composições e métodos de anticorpos anti-tnf para o tratamento da artrite idiopática juvenil
|
WO2020152544A1
(en)
|
2019-01-23 |
2020-07-30 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
CN113840838A
(zh)
|
2019-03-14 |
2021-12-24 |
詹森生物科技公司 |
用于产生抗tnf抗体组合物的制造方法
|
JP2022525145A
(ja)
|
2019-03-14 |
2022-05-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il12/il23抗体組成物を生成するための製造方法
|
EP3938391A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Verfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
EP3938392A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Verfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
KR20210141583A
(ko)
|
2019-03-18 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il-12/il-23 항체를 사용한 소아 대상의 건선 치료 방법
|
JP2022534020A
(ja)
|
2019-05-23 |
2022-07-27 |
ヤンセン バイオテツク,インコーポレーテツド |
Il-23及びtnfアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
|
MX2021014882A
(es)
|
2019-06-03 |
2022-03-25 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
|
EP3976648A1
(de)
|
2019-06-03 |
2022-04-06 |
Janssen Biotech, Inc. |
Anti-tnf-antikörperzusammensetzungen und verfahren zur behandlung von aktiver psoriasis-arthritis
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
CN115666621A
(zh)
|
2020-01-13 |
2023-01-31 |
度勒科特公司 |
具有减少的杂质的持续释放药物递送系统及相关方法
|
CN111450310A
(zh)
*
|
2020-03-03 |
2020-07-28 |
劳龙斯(上海)医药科技有限公司 |
一种新型液体伤口敷料及其制备方法
|
CN111714692B
(zh)
*
|
2020-07-07 |
2022-04-15 |
华熙生物科技股份有限公司 |
一种皮肤创面保护组合物及其制备方法
|
EP4305062A1
(de)
|
2021-03-12 |
2024-01-17 |
Janssen Biotech, Inc. |
Verfahren zur behandlung von patienten mit psoriasisarthritis mit unzureichender reaktion auf eine tnf-therapie mit anti-il23-spezifischem antikörper
|
IL305802A
(en)
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
A safe and effective method for the treatment of rheumatoid arthritis with a specific anti-IL23 antibody
|
AU2022306973A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
US20230042465A1
(en)
|
2021-07-09 |
2023-02-09 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
|
AU2022306144A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023084488A1
(en)
|
2021-11-15 |
2023-05-19 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
WO2023187707A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of treating mild to moderate psoriasis with il-23 specific antibody
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|